Hyundai Pharm

Industry · 7 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Enrolling By Invitation	To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension, Primary Hypercholesterolaemia	Phase 3	2025-04-22
Recruiting	To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mell Type 2 Diabetes Mellitus (T2DM)	Phase 2	2024-12-12
Recruiting	To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults Type 2 Diabetes, Dyslipidemias	Phase 1	2024-06-20
Completed	Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults Healthy	Phase 1	2022-12-28
Completed	Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet a Type 2 Diabetes Mellitus	Phase 2	2022-06-17
Completed	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects Contraception	Phase 1	2022-01-11
Completed	Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Pat Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis	Phase 3	2017-01-01